Drugs · acquisition-cost intelligence
KENALOG-40
Triamcinolone acetonide· ingredient triamcinoloneCorticosteroids· TRIAMCINOLONE ACETONIDE 200 mg/5mL; TRIAMCINOLONE ACETONIDE 400 mg/10mL; TRIAMCINOLONE ACETONIDE 40 mg/mL; TRIAMCINOLONE ACETONIDE 80 mg/mL
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per ML
$6.45
NADAC — pharmacy acquisition cost, not a retail/cash price
Acquisition-cost history
Weekly NADAC per ML — the trend nobody else shows. 6 weeks.
2025-12-172026-05-20
Same-ingredient options by acquisition cost
Other triamcinolone products, cheapest acquisition cost first. Per ML — confirm strength/form equivalence before switching.
| Product | NADAC / ML | vs this |
|---|---|---|
| triamcinolone acetonide | $0.07238 | −$6.38 |
| Dermavyx | $0.08272 | −$6.37 |
| Triasil | $0.11513 | −$6.33 |
| Triamcinolone Acetonide | $0.18453 | −$6.26 |
| NYSTATIN AND TRIAMCINOLONE ACETONIDE | $0.23054 | −$6.22 |
| triamcinolone acetonide | $0.27895 | −$6.17 |
| nystatin and triamcinolone acetonide | $0.28013 | −$6.17 |
| TRIAMCINOLONE ACETONIDE | $0.31654 | −$6.13 |
Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.